Daewoong secures global rights to obesity microneedle patch

Daewoong Pharmaceutical said Wednesday it has signed an exclusive global licensing agreement with its R&D affiliate, Daewoong Therapeutics, to commercialize microneedle-based therapies targeting the fast-growing obesity treatment market. Under the agreement, Daewoong Pharmaceutical secured exclusive worldwide commercialization rights to a patented microneedle patch platform developed by Daewoong Therapeutics. In return, it will lead the global marketing, regulatory strategy and large-scale manuf

By The Korea Herald